● Armata Pharmaceuticals shares have fallen sharply, most recently closing at $4.42, down 12.82%, after reporting Q2 2026Net Incomeof about $74.1 million, driven primarily by a roughly $91.0 million non-cash gain from a change in theFair Valueof its convertible loan.
● Bimergen Energy shares have fallen sharply, most recently closing at $3.09, down 10.60%, days after reporting Q2 2026Revenueof $7.9 million,Net Incomeof $1.6 million, and adjusted EBITDA of $3.9 million.
● Better Home & Finance shares have fallen sharply, most recently closing at $11.60, down 10.97%, after the board moved to permanently remove founder Vishal Garg as CEO.
● BioAge Labs shares have fallen sharply, most recently closing at $9.69, down 9.86%, with no specific single catalyst identified, extending a drawdown that one data provider characterized as roughly two-thirds off its post-IPO highs.
● AIAI Holdings shares have fallen sharply, most recently closing at $4.53, down 13.30%, well below their $15.09 first-day close.
● AIOS Tech shares have fallen sharply, most recently closing at $13.42, down 13.31%, and far below their 52-week high of about $91.40.
● REalloys shares have fallen sharply, most recently closing at $11.07, down 11.51%, even as the stock remained up meaningfully over the trailing month.
● Autonomix Medical shares have fallen sharply, most recently closing at $5.27, down 10.83%, following a 1-for-21 reverse split effective June 24, 2026.
● Advance Auto Parts shares have fallen sharply, most recently closing at $42.39, down 24.55%, after Q2 fiscal 2026Revenueof about $2.0 billion came in below the roughly $2.04 billion analysts expected.
● Aardvark Therapeutics shares have fallen sharply, most recently closing at $5.89, down 12.74%, near the bottom of a 52-week range of about $3.35 to $17.94.